These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17824843)

  • 1. Expression and purification of human vascular-endothelial-growth-factor-receptor-2 tyrosine kinase in Streptomyces for inhibitor screening.
    Liu C; Guo L; Yao C; Zhang R; Li Y
    Biotechnol Appl Biochem; 2008 Jun; 50(Pt 2):113-9. PubMed ID: 17824843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and development of a peptide substrate-based phosphate transfer assay for the human vascular endothelial growth factor receptor-2 tyrosine kinase.
    Zhao G; Peery RB; Yingling JM
    Anal Biochem; 2007 Jan; 360(2):196-206. PubMed ID: 17141171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma.
    Ebos JM; Bocci G; Man S; Thorpe PE; Hicklin DJ; Zhou D; Jia X; Kerbel RS
    Mol Cancer Res; 2004 Jun; 2(6):315-26. PubMed ID: 15235107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and function identification of extracellular domain 3 of human vascular endothelial growth factor receptor KDR].
    Zhang J; Zhang Y; Li H; Chen W; Zhang T; Wang M
    Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1962-7. PubMed ID: 19256346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity.
    Yamamoto A; Watanabe H; Sueki H; Nakanishi T; Yasuhara H; Iijima M
    J Dermatol; 2007 Jul; 34(7):419-29. PubMed ID: 17584317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the vascular endothelial growth factor-receptor system in the porcine endometrium throughout the estrous cycle and early pregnancy.
    Kaczmarek MM; Waclawik A; Blitek A; Kowalczyk AE; Schams D; Ziecik AJ
    Mol Reprod Dev; 2008 Feb; 75(2):362-72. PubMed ID: 17874446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Expression and Purification of the Catalytic Domain of Human Vascular Endothelial Growth Factor Receptor 2 in Escherichia coli.
    Wei J; Cao X; Zhou S; Chen C; Yu H; Zhou Y; Wang P
    J Microbiol Biotechnol; 2015 Aug; 25(8):1227-33. PubMed ID: 25907066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model for random screening inhibitors of vascular endothelial growth factor receptor 1 kinase.
    Zhuang SF; Zhou CH; Qian J; Qian Z; Shibuya M; Ye QZ
    Acta Pharmacol Sin; 2002 Feb; 23(2):117-23. PubMed ID: 11866870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor in chronic rat allograft nephropathy.
    Malmström NK; Kallio EA; Rintala JM; Nykänen AI; Räisänen-Sokolowski AK; Paavonen T; Lemström KB; Koskinen PK
    Transpl Immunol; 2008 May; 19(2):136-44. PubMed ID: 18503889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2.
    Alonso V; de Gortázar AR; Ardura JA; Andrade-Zapata I; Alvarez-Arroyo MV; Esbrit P
    J Cell Physiol; 2008 Dec; 217(3):717-27. PubMed ID: 18651620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S; Bezdekova M; Brychta T; Tichy M
    Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
    Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
    Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and purification of the catalytic domain of human vascular endothelial growth factor receptor 2 for inhibitor screening.
    Zhong L; Guo XN; Zhang XH; Wu ZX; Luo XM; Jiang HL; Lin LP; Zhang XW; Ding J
    Biochim Biophys Acta; 2005 Apr; 1722(3):254-61. PubMed ID: 15715968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and localization of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in human epidermal appendages: a comparison study by immunofluorescence.
    Man XY; Yang XH; Cai SQ; Bu ZY; Wu XJ; Lu ZF; Zheng M
    Clin Exp Dermatol; 2009 Apr; 34(3):396-401. PubMed ID: 19309374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening.
    Usui T; Ban HS; Kawada J; Hirokawa T; Nakamura H
    Bioorg Med Chem Lett; 2008 Jan; 18(1):285-8. PubMed ID: 17983745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of benzamides and benzamidines as selective inhibitors of VEGFR tyrosine kinases.
    Nakamura H; Sasaki Y; Uno M; Yoshikawa T; Asano T; Ban HS; Fukazawa H; Shibuya M; Uehara Y
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5127-31. PubMed ID: 16893647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.